BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8977193)

  • 1. Analysis of the contact sites on the CD4 molecule with class II MHC molecule: co-ligand versus co-receptor function.
    Huang B; Yachou A; Fleury S; Hendrickson WA; Sekaly RP
    J Immunol; 1997 Jan; 158(1):216-25. PubMed ID: 8977193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4.
    Vignali DA; Vignali KM
    J Immunol; 1999 Feb; 162(3):1431-9. PubMed ID: 9973399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles.
    Fleury S; Huang B; Zerbib A; Croteau G; Long EO; Sekaly RP
    J Immunol; 1996 Mar; 156(5):1848-55. PubMed ID: 8596036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
    Brogdon J; Eckels DD; Davies C; White S; Doyle C
    J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.
    Pan S; Trejo T; Hansen J; Smart M; David CS
    J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of the CD4-dependent T cell response by J2, a novel nonpeptide organic ligand of CD4 D1.
    Xiao H; Feng JN; He XH; Zhang H; Zhang JR; Zhang L; Yu M; Huang YF; Li S; Shen BF; Li Y
    Mol Immunol; 2007 Feb; 44(5):784-95. PubMed ID: 16787663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential requirements for CD4 in TCR-ligand interactions.
    Vidal K; Daniel C; Hill M; Littman DR; Allen PM
    J Immunol; 1999 Nov; 163(9):4811-8. PubMed ID: 10528181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
    Neumann J; Koch N
    J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.
    Patarroyo ME; Alba MP; Vargas LE; Silva Y; Rosas J; Rodríguez R
    Biochemistry; 2005 May; 44(18):6745-54. PubMed ID: 15865420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
    Chen Y; Shi Y; Cheng H; An YQ; Gao GF
    IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues.
    Lian RH; Li Y; Kubota S; Mager DL; Takei F
    J Immunol; 1999 Jun; 162(12):7271-6. PubMed ID: 10358175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CD4 hinge region in GP120 utilization by immunoglobulin domain 1.
    Murray JL; Hu QX; Navenot JM; Peiper SC
    Biochem Biophys Res Commun; 2002 Mar; 292(2):449-55. PubMed ID: 11906183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.